Followers | 0 |
Posts | 199 |
Boards Moderated | 0 |
Alias Born | 01/07/2005 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, April 16, 2005 5:35:10 PM
Yes, it appeared to be at the end of the trial to me too.
The interesting point that led me to place this on the board was that I am estimating the information to be from 2002 and back then they were looking for a partner. To the point, DNAP is who they selected and it appears after very careful consideration and possibly beating out several companies considering we are talking about 3 years. As I and others on this board have stated, it is of note that Havard / Beth Israel Deaconess Medical Center selected DNAPrint. Important note, I found no other company related to PT-401 in a partnership with Beth Israel Deaconess Medical Center prior to DNAP's relationship with them.
State of Development:
BIDMC seeks a corporate partner to aid in the development, including scale up and primate studies, of these proteins.
Big Blue
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM